Muscle Cell Mediated Therapy for Tongue Dysphagia: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Latest Information Update: 19 May 2022
At a glance
- Drugs Iltamiocel (Primary)
- Indications Oropharyngeal cancer; Squamous cell cancer
- Focus Adverse reactions
- 10 May 2022 Planned End Date changed from 1 Jun 2025 to 1 Dec 2026.
- 10 May 2022 Planned primary completion date changed from 1 Jun 2025 to 1 Dec 2026.
- 14 Jan 2022 Planned End Date changed from 1 Dec 2021 to 1 Jun 2025.